Arcus Biosciences Completes Stock Offering, Raises Approximately $141.6 Million
Arcus Biosciences, Inc. (NYSE: RCUS) announced on February 18, 2025, that it has entered into an underwriting agreement with Goldman Sachs & Co. LLC and Leerink Partners LLC for the offering, issuance, and sale of 13,636,364 shares of common stock. The shares were priced at $11.00 per share, resulting in a total offering value of […]
Arcus Biosciences, Inc. (NYSE: RCUS) announced on February 18, 2025, that it has entered into an underwriting agreement with Goldman Sachs & Co. LLC and Leerink Partners LLC for the offering, issuance, and sale of 13,636,364 shares of common stock. The shares were priced at $11.00 per share, resulting in a total offering value of […]
